Found 20 matching trials
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia PHASE3 This is a multicenter, multinational, open-label, one-way cross-over, Phase...
Show More Status
Active Not Recruiting
Location
Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
Learn More & Join Trial
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B PHASE3 The purpose of this clinical trial is to learn about the safety and effects...
Show More Location
Intermountain - Primary Children's Hospital
Learn More & Join Trial
Treatment of Hemophilia A Patients With FVIII Inhibitors N/A This is a non-interventional, multicenter, observational, international stu...
Show More Location
Arthur M. Blank Hospital
Learn More & Join Trial
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B PHASE3 Treatment with PF-06741086 is anticipated to demonstrate a clinically relev...
Show More Location
USF Health Morsani Center For Advanced Healthcare
Learn More & Join Trial
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B PHASE3 To evaluate the safety (acute adverse effects associated with infusions, an...
Show More Location
Multiple Locations
Learn More & Join Trial
Factor Product Utilization and Health Outcomes in Patients With Hemophilia N/A Recombinant factor VIII Fc (rFVIIIFc) and recombinant factor IX Fc (rFIXFc)...
Show More Location
BC Hemophilia Adult Program
Learn More & Join Trial
Movement Visualization in Patients With Hemophilic Arthropathy NA Background. The recurrence of hemarthrosis in patients with hemophilia favo...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS N/A This 6-month prospective outcomes study addresses the association between t...
Show More Location
Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center
Learn More & Join Trial
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors PHASE3 Study B7841007 is an open-label extension study to assess the long-term saf...
Show More Location
University of Iowa
Learn More & Join Trial
A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis PHASE3 Primary Objective:
To characterize the frequency of bleeding episodes (BE)...
Show More Location
Investigational Site Number 0139
Learn More & Join Trial